Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03854903 |
| Title | WI231696: Bosutinib, Palbocicilib and Fulvestrant for HR+HER2- Advanced Breast Cancer Refractory to a CDK4/6 Inhibitor |
| Recruitment | Active, not recruiting |
| Gender | female |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Georgetown University |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Lombardi Comprehensive Cancer Center | Washington | District of Columbia | 20007 | United States | Details |